跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
frontotemporal dementia therapy
首页
药物
frontotemporal dementia therapy
frontotemporal dementia therapy
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
GENE THERAPY FOR FRONTOTEMPORAL DEMENTIA
EP 4615518 A1
申请人: ALEXION PHARMA INTERNATIONAL OPERATIONS LTD
优先权: 2022
CN
EP
US
WO
4 件公开
ADENO-ASSOCIATED VIRUS (AAV) SYSTEMS FOR TREATMENT OF PROGRANULIN ASSOCIATED NEURODEGENERATIVE DISEASES OR DISORDERS
EP 4048799 A4
申请人: APPLIED GENETIC TECH CORPORATION
优先权: 2019
CN
EP
US
3 件公开
Gene therapy for Alzheimer's disease
US 12497608 B2
申请人: BRIGHAM & WOMENS HOSPITAL INC
优先权: 2018
CN
US
2 件公开
EP 3976637 A4
申请人: BRIGHAM & WOMENS HOSPITAL INC
优先权: 2019
EP
US
2 件公开
TREATMENT FOR NEURODEGENERATIVE DISEASES
EP 4146797 A1
申请人: ORCHARD THERAPEUTICS EUROPE LTD
优先权: 2020
EP
WO
2 件公开
GENE THERAPY FOR TREATMENT OF PROTEIN MISFOLDING DISEASES
EP 4705326 A1
申请人: RES INST NATIONWIDE CHILDRENS HOSPITAL
优先权: 2023
EP
WO
2 件公开
AGENTS, USES AND METHODS FOR THERAPY
CN 119161480 A
申请人: H LUNDBECK AS
优先权: 2017
CN
2 件公开
Human TRPCC cation channel and uses
US 2003232339 A1
申请人: SHU YOUMIN
优先权: 2002
US
HIP/PAP PROTEIN OR DERIVATIVES THEREOF FOR THE TREATMENT OF COGNITIVE DISORDERS RELATED
CN 121604971 A
申请人: HEALTH ON AGING BVBA
优先权: 2023
CN
药物
反馈